Ex parte LICHT - Page 5




          Appeal No. 95-0972                                         Page 5           
          Application No. 07/650,453                                                  


               In reaching our decision in this appeal, we have given                 
          careful consideration to the appellant's specification and                  
          claims, to the applied prior art references, and to the                     
          respective positions articulated by the appellant and the                   
          examiner.  As a consequence of our review, we make the                      
          determinations which follow.                                                


               Before addressing the examiner's rejections of                         
          independent claim 1, it is an essential prerequisite that the               
          claimed subject matter be fully understood.  Analysis of                    
          whether a claim is patentable under 35 U.S.C. §§ 102 and 103                
          begins with a determination of the scope of the claim.  Claim               
          interpretation must begin with the language of the claim                    
          itself.  See Smithkline Diagnostics, Inc. v. Helena                         
          Laboratories Corp., 859 F.2d 878, 882, 8 USPQ2d 1468, 1472                  
          (Fed. Cir. 1988).  Accordingly, we will initially direct our                
          attention to claim 1 to derive an understanding of the scope                
          and content thereof.                                                        


               Before turning to the proper construction of claim 1, it               
          is important to review some basic principles of claim                       







Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007